Key facts
- This page summarizes Sim Farar's Form 4/A - Amendment filing for cbdMD, Inc. (YCBD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 05 Oct 2021, 13:42.
Sim Farar - 12 Mar 2021 Form 4/A - Amendment Insider Report for cbdMD, Inc. (YCBD)
- Reporting relationship
- Director
- Issuer ticker
- YCBD
- Reported as of
- 12 Mar 2021
- Net transaction value
- $0
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 05 Oct 2021, 13:42:57 UTC
- Original report date
- 16 Mar 2021
- Next SEC filing
- 04 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sim Farar
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sim Farar filed Form 4/A - Amendment for cbdMD, Inc. (YCBD) on 05 Oct 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
YCBD
transaction
Common stock
Award
- Transaction value
- $0
- Shares
- +7,000
- Change %
- Price
- $0.000000
- Shares after
- 7,000
- Date
- 12 Mar 2021
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The grant was exempt from Section 16(b) under the Securities Exchange Act of 1934 by virtue of Rule 16b-3 promulgated thereunder as it was approved in advance by the Issuer's Compensation, Corporate Governance and Nominating Committee, which is comprised of three non-employee directors. The restricted stock units vest as follows: 2,000 vested on March 12, 2021 and the remaining 5,000 vest quarterly in equal increments over a one year period from the grant date with the last vesting being on March 12, 2022, subject to continued service as a director of the Issuer on each applicable vesting date. Shares of common stock will be delivered to the Reporting Person upon the vesting of the restricted stock units. The restricted stock units were issued under the 2021 Equity Compensation Plan as compensation to the Reporting Person for his services on the Issuer's Board of Directors for the Board term beginning March 12, 2021.
SEC remarks
The original Form 4 filed on March 16, 2021 is amended by this Form 4 to disclose the restricted stock units as a non-derivative security. No other changes have been made to the original Form 4.